Akzo Nobel N.V.
AKZA.AS · AMS
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | €2,547 | €2,626 | €2,613 | €2,619 |
| % Growth | -3% | 0.5% | -0.2% | – |
| Cost of Goods Sold | €1,520 | €1,588 | €1,565 | €1,593 |
| Gross Profit | €1,027 | €1,038 | €1,048 | €1,026 |
| % Margin | 40.3% | 39.5% | 40.1% | 39.2% |
| R&D Expenses | €0 | €0 | €0 | €296 |
| G&A Expenses | €0 | €826 | €855 | €898 |
| SG&A Expenses | €743 | €826 | €855 | €898 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | -€2 | €1 | -€295 |
| Operating Expenses | €743 | €824 | €856 | €899 |
| Operating Income | €284 | €214 | €192 | €127 |
| % Margin | 11.2% | 8.1% | 7.3% | 4.8% |
| Other Income/Exp. Net | -€380 | -€35 | -€23 | -€32 |
| Pre-Tax Income | -€96 | €179 | €169 | €95 |
| Tax Expense | €94 | €44 | €48 | €59 |
| Net Income | -€194 | €124 | €107 | €21 |
| % Margin | -7.6% | 4.7% | 4.1% | 0.8% |
| EPS | -1.13 | 0.73 | 0.63 | 0.12 |
| % Growth | -254.8% | 15.9% | 425% | – |
| EPS Diluted | -1.13 | 0.72 | 0.62 | 0.12 |
| Weighted Avg Shares Out | 171 | 171 | 171 | 171 |
| Weighted Avg Shares Out Dil | 171 | 172 | 173 | 171 |
| Supplemental Information | – | – | – | – |
| Interest Income | €12 | €18 | €0 | €0 |
| Interest Expense | €45 | €68 | €30 | €36 |
| Depreciation & Amortization | €94 | €92 | €94 | €94 |
| EBITDA | €34 | €339 | €293 | €225 |
| % Margin | 1.3% | 12.9% | 11.2% | 8.6% |